Analysis Of Income And Expense [Abstract]

BioInvent International - Filing #689618

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
326 126 SEK
19 384 SEK
Material income and expense [abstract]
Research and development expense
325 929 SEK
258 337 SEK
Finance income (cost)
8 418 SEK
94,000 SEK
Other operating income (expense)
739,000 SEK
470,000 SEK
Miscellaneous other operating expense
1 107 SEK
429,000 SEK
Selling, general and administrative expense [abstract]
Selling, general and administrative expense
50 750 SEK
39 438 SEK
Expenses by nature [abstract]
Expenses, by nature
377 047 SEK
297 734 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
42 503 SEK
42 503 SEK
278 444 SEK
278 444 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
42 503 SEK
278 444 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.